CN101979081A - Plaster for treating arthritis and hyperosteogeny - Google Patents
Plaster for treating arthritis and hyperosteogeny Download PDFInfo
- Publication number
- CN101979081A CN101979081A CN2010105131063A CN201010513106A CN101979081A CN 101979081 A CN101979081 A CN 101979081A CN 2010105131063 A CN2010105131063 A CN 2010105131063A CN 201010513106 A CN201010513106 A CN 201010513106A CN 101979081 A CN101979081 A CN 101979081A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- plaster
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 25
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 22
- 206010003246 arthritis Diseases 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 238000007796 conventional method Methods 0.000 claims abstract description 8
- 239000009490 scorpio Substances 0.000 claims description 13
- 241001489978 Eupolyphaga Species 0.000 claims description 12
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 12
- 241000180649 Panax notoginseng Species 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 12
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 12
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 8
- 241001180876 Saposhnikovia Species 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000004576 sand Substances 0.000 claims description 2
- 230000036407 pain Effects 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 14
- 238000002360 preparation method Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 241000489492 Arisaema Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000004370 Pastinaca sativa Species 0.000 abstract 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000002674 ointment Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000013219 diaphoresis Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a plaster for treating arthritis and hyperosteogeny, and relates to a Chinese medicinal plaster for treating arthritis and hyperosteogeny. The plaster is characterized by comprising the following raw materials in part by weight: 200 to 500 parts of kusnezoff monkshood root, 200 to 500 parts of incised notopterygium rhizome, 200 to 300 parts of arisaema root, 200 to 300 parts of dahurian angelica root, 100 to 300 parts of corydalis root, 200 to 400 parts of Chinese angelica, 100 to 200 parts of dried ginger, 200 to 400 parts of nutgrass galingale rhizome, 50 to 100 parts of borneol, 200 to 500 parts of pubescent angelica root, 200 to 300 parts of root of pseudo-ginseng, 100 to 300 parts of rhubarb and 100 to 300 parts of ephedra, wherein the raw materials are prepared into the plaster by a conventional method. Moreover, self-heal, Chinese starjasmine stem, ground beetle, scorpion, cassia twig, parsnip, grass-leaf sweelflag rhizome and rosin also can be added. The medicament has the advantages that: 1, the preparation process is simple, and the medicament is convenient for production; 2, the pain stopping effect is good, the healing rate is high, and proved by 278 cases of clinical experiments, the total effective rate is 99.3 percent; 3, because the pure Chinese medicinal formula is used, the medicament has low toxic or side effect; and 4, the cost is low, so the medicament is easily accepted by patients.
Description
Technical field
The present invention relates to the Chinese medicine medicine, especially for the Chinese medicine ointment of treatment of arthritis and hyperosteogeny.
Background technology
Arthritis and hyperosteogeny are the commonly encountered diseases frequently-occurring diseases.Particularly hyperosteogeny is a great problem of current international medical community, mostly occurs person in middle and old age positions such as waist, lower limb, shoulder and arm, when beginning to take place, sensation ache, numbness can not be worked when serious, difficulty in walking causes serious physiology and mental anguish to the patient.At present domestic and international each R﹠D institution of universities and colleges, the traditional Chinese medical science, doctor trained in Western medicine have all dropped into a large amount of funds and have carried out the emphasis tackling key problem, so far there is not ideal treatment way, part hospital takes methods such as operation, ozone, threading, plaster to treat, but unsatisfactory curative effects all, particularly the expenses of surgical treatment height has a big risk, cure the symptoms, not the disease, be difficult to eradicate.Lack person's half a year, many persons 2～3 years, often recurrence once more.The treatment how effectively to solve hyperosteogeny is many problems of being paid close attention to.
Summary of the invention
The purpose of this invention is to provide a kind of make simple, easy to use, cost is lower, the effect plaster of treatment of arthritis and hyperosteogeny preferably.
The objective of the invention is to realize by following scheme: the plaster of a kind of treatment of arthritis and hyperosteogeny is characterized in that comprising following raw material by weight: 200～500 parts of Radix Aconiti Kusnezoffii, 200～500 parts of Rhizoma Et Radix Notopterygiis, 200～300 parts of Rhizoma Arisaematiss, 200～300 parts of the Radixs Angelicae Dahuricae, 100～300 parts of Rhizoma Corydalis, 200～400 parts of Radix Angelicae Sinensis, 100～200 parts of Rhizoma Zingiberiss, 200～400 parts of Rhizoma Cyperis, 50～100 parts of Borneolum Syntheticums, 200～500 parts of Radix Angelicae Pubescentiss, 200～300 parts of Radix Notoginseng, 100～300 parts of Radix Et Rhizoma Rhei, 100～300 parts in Herba Ephedrae.
Preferable range is: 300～400 parts of Radix Aconiti Kusnezoffii, 300～400 parts of Rhizoma Et Radix Notopterygiis, 220～280 parts of Rhizoma Arisaematiss, 220～280 parts of the Radixs Angelicae Dahuricae, 150～250 parts of Rhizoma Corydalis, 250～350 parts of Radix Angelicae Sinensis, 120～180 parts of Rhizoma Zingiberiss, 250～350 parts of Rhizoma Cyperis, 60～90 parts of Borneolum Syntheticums, 300～400 parts of Radix Angelicae Pubescentiss, 220～280 parts of Radix Notoginseng, 150～250 parts of Radix Et Rhizoma Rhei, 150～250 parts in Herba Ephedrae.
Preferred plan is: 350 parts of Radix Aconiti Kusnezoffii, 350 parts of Rhizoma Et Radix Notopterygiis, 250 parts of Rhizoma Arisaematiss, 250 parts of the Radixs Angelicae Dahuricae, 200 parts of Rhizoma Corydalis, 300 parts of Radix Angelicae Sinensis, 150 parts of Rhizoma Zingiberiss, 300 parts of Rhizoma Cyperis, 75 parts of Borneolum Syntheticums, 350 parts of Radix Angelicae Pubescentiss, 250 parts of Radix Notoginseng, 200 parts of Radix Et Rhizoma Rhei, 200 parts in Herba Ephedrae.
The present invention also can further realize by following scheme:
Option A: in described main formula case, also can contain following raw material: 200～300 parts of Spica Prunellaes, 100～200 parts of Caulis Trachelospermis, 50～100 parts of eupolyphaga, 50～100 parts of Scorpio.
Preferable range is: 220～280 parts of Spica Prunellaes, 120～180 parts of Caulis Trachelospermis, 60～90 parts of eupolyphaga, 60～90 parts of Scorpio.
Preferred plan is: 250 parts of Spica Prunellaes, 150 parts of Caulis Trachelospermis, 75 parts of eupolyphaga, 75 parts of Scorpio.
Option b: in described main formula case, also can contain following raw material: 200～400 parts of Ramulus Cinnamomi, 200～400 parts of Radix Saposhnikoviaes, 200～400 parts of Rhizoma Acori Graminei, 100～200 parts of Colophonium.
Preferable range is: 250～350 parts of Ramulus Cinnamomi, 250～350 parts of Radix Saposhnikoviaes, 250～350 parts of Rhizoma Acori Graminei, 120～180 parts of Colophonium.
Preferred plan is: 300 parts of Ramulus Cinnamomi, 300 parts of Radix Saposhnikoviaes, 300 parts of Rhizoma Acori Graminei, 150 parts of Colophonium.
Scheme C: in described main formula case, also can contain following raw material: 200～300 parts of Spica Prunellaes, 100～200 parts of Caulis Trachelospermis, 50～100 parts of eupolyphaga, 50～100 parts of Scorpio, 200～400 parts of Ramulus Cinnamomi, 200～400 parts of Radix Saposhnikoviaes, 200～400 parts of Rhizoma Acori Graminei, 100～200 parts of Colophonium.
Preferable range is: 220～280 parts of Spica Prunellaes, 120～180 parts of Caulis Trachelospermis, 60～90 parts of eupolyphaga, 60～90 parts of Scorpio, 250～350 parts of Ramulus Cinnamomi, 250～350 parts of Radix Saposhnikoviaes, 250～350 parts of Rhizoma Acori Graminei, 120～180 parts of Colophonium.
Preferred plan is: 250 parts of Spica Prunellaes, 150 parts of Caulis Trachelospermis, 75 parts of eupolyphaga, 75 parts of Scorpio, 300 parts of Ramulus Cinnamomi, 300 parts of Radix Saposhnikoviaes, 300 parts of Rhizoma Acori Graminei, 150 parts of Colophonium.
The preparation method of medicine of the present invention is: make plaster with conventional method.That is, the A group: Radix Aconiti Kusnezoffii Preparata, Rhizoma Arisaematis, Rhizoma Corydalis, Radix Angelicae Pubescentis, Radix Angelicae Sinensis, Radix Notoginseng, Spica Prunellae, Caulis Trachelospermi, eupolyphaga, Scorpio, broken back is standby; The B group: Rhizoma Et Radix Notopterygii, the Radix Angelicae Dahuricae, Rhizoma Zingiberis, Rhizoma Cyperi (processed), Radix Et Rhizoma Rhei, Herba Ephedrae, Ramulus Cinnamomi, Radix Saposhnikoviae, Rhizoma Acori Graminei, Colophonium, standby after pulverizing; The C group: it is standby that Borneolum Syntheticum is pulverized the back; Get Oleum sesami and go into and change slow fire after a pot intense fire boils, A is organized raw material put into, stir, about 30-40 minute fried extremely withered and yellow, pulls out; Be lowered to B group slow fire again, stirred about 20 minutes, from fire, cool after-filtration after filtering with fine sand cloth, is gone up intense fire again, fire to dripping into pearl, is removed in following Plumbum preparatium, and the stirring of cool slightly Borneolum Syntheticum down is even.Time spent spreads out on the thick cloth and gets final product.Wherein, Radix Aconiti Kusnezoffii Preparata referred to steam about 30 minutes, dried or fry dried; Rhizoma Cyperi (processed) refers to Rhizoma Cyperi is poured in the pot, sprays into yellow wine and soaks into, and fries and does.
Among the present invention,--Radix Aconiti Kusnezoffii, expelling wind and removing dampness, antalgic.--Rhizoma Et Radix Notopterygii, cold expelling dispels the wind, dehumidifying, pain relieving.--the Rhizoma Arisaematis drying dampness to eliminate phlegm, expelling wind and relieving convulsion mass dissipating and swelling eliminating.--the diffusing wind dehumidifying of the Radix Angelicae Dahuricae, understand things pain-stopping, detumescence and apocenosis.--Rhizoma Corydalis is invigorated blood circulation, promoting the circulation of QI, pain relieving.--Radix Angelicae Sinensis, enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.--Rhizoma Zingiberis, warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, the dampness expectorant.--Rhizoma Cyperi, promoting QI circulation for relieving depression, menstruction regulating and pain relieving.--the Borneolum Syntheticum refreshment of having one's ideas straightened out, clearing away heat to alleviate pain.--Radix Angelicae Pubescentis expelling wind and removing dampness, numbness relieving and pain relieving.--the hemostasis of Radix Notoginseng dissipating blood stasis, subduing swelling and relieving pain.--Radix Et Rhizoma Rhei purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.--Herba Ephedrae relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing, inducing diuresis to remove edema.--Spica Prunellae, antipyretic; Relieve inflammation or internal heat, make eye bright, eliminating stagnation, detumescence.--Caulis Trachelospermi dispelling wind and removing obstruction in the collateral, removing heat from blood detumescence.--eupolyphaga, removing blood stasis, removing mass, collateral dredging, reason are hindered.--Scorpio, endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.--Ramulus Cinnamomi, diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI.--Radix Saposhnikoviae, inducing diaphoresis to dispel wind wins and wets, relieving convulsion.--Rhizoma Acori Graminei, removing dampness appetizing, the eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae.--Colophonium, dispel the wind, dampness, evacuation of pus is drawn out pus by applying a plaster to the affected part, granulation promoting, pain relieving.
In prescription, adhere to drastically removing blood stasis and resolving static blood, collateral dredging toxin expelling, promoting the circulation of QI for relieving swelling, the double principle of controlling of table reason, adopt above all medicines to share, complement each other, start with from the pathology cause of disease of hyperosteogeny, reach the purpose of thorough radical cure.Medicine of the present invention has effects such as drastically removing blood stasis and resolving static blood, collateral dredging toxin expelling, promoting the circulation of QI for relieving swelling, strengthening the body resistance.The medicine that adopts method provided by the invention to make is used for the treatment of arthritis and hyperosteogeny, and through clinical observation, this medicine improves the symptom determined curative effect to reducing swelling and alleviating pain, does not find toxicity and untoward reaction, and has the advantage of significant instant effect, nothing recurrence.
The beneficial effect of medicine of the present invention is: 1, processing technology is simple, is convenient to produce.2, good analgesic effect, the cure rate height.Show that through 278 routine clinical trials total effective rate is 99.3%.3, use pure Chinese medicine preparation, toxic and side effects is little.4, cost is low, and the patient is easy to accept.
Below by clinical observation on the therapeutic effect test, further set forth the beneficial effect of medicine of the present invention.
Testing data:
1, cure mainly: the neck that cervical vertebra, thoracic vertebra, lumbar vertebra hyperosteogeny and prolapse of lumbar intervertebral disc, bulging cause, shoulder, waist, have a pain in the leg the pain; Osteoarthritis such as arthritis, spondylitis, lumbar muscle strain.
2, case statistics: select patient's standard: 1. following symptom is arranged: waist, lower limb, arm begin to ache, numb, pain, are difficult to activity when serious; 2. be defined as hyperosteogeny through perspective, film making, CT.
Treat 278 examples, among the patient, male's 155 examples, women's 123 examples, age distribution is: 5 examples below 30 years old, 31～40 years old 31 examples, 41～50 years old 52 example, 50～60 years old 103 example, 87 examples more than 60 years old, maximum 71 years old age, minimal ages 26 years old, sick elder 15 years, weak point person 3 months, the patient is in the majority with lumbar vertebra hyperosteogeny.
3, Therapeutic Method: get it filled about cream 10 grams, on the cloth that evenly is applied to, form 11 centimetres of circles of about diameter, be affixed on the affected part again, changed dressings once in per three days, 25 days is a course of treatment.
4, contraindication: period in a medicine, avoid eating anything raw or cold, spicy food, do not do ass work, do not have a bath with cold water.Anemia of pregnant woman's forbidding is forbidden this product allergy sufferers.
5, efficacy assessment standard:
Produce effects: pain disappears, and 3 months no rebound phenomenons are observed in joint and along freely.Take a turn for the better: intermission prolongation, pain disappear substantially, and life activity is obviously convenient.Invalid: as not reach improvement target person.
6, therapeutic effect:
68 days courses of treatment of mean treatment, the shortest 15 days, the longest 250 days, medication produce effects 231 examples account for 83.1%, and 45 examples that take a turn for the better account for 16.2%, and invalid 2 examples account for 0.7%, total effective rate 99.3%.
7, model case introduction:
Case 1: Huang, the man, 57 years old, Hua County, Henan Province Lao Dianzhen Geng Fan people from village, the two kneecap matter hypertrophy of patient have bony spur, painful can not standing up, sick existing about 15 years, to do the treatment that overdoes in the provincial capital, and paste multiple plaster and lose effect, invention ointment 2 months loses money in a business in May, 2010.Pain disappears entirely, can stand up freely, follows up a case by regular visits to and does not have recurrence.
Case 2: Zhang, the woman, 51 years old, road junction people from town, Hua County, Henan Province, the two knee joints of patient are painful, squat down and can not stand up, and ill 4 years, invention ointment 2 months lost money in a business in June, 2010.Pain disappears entirely, can stand up freely, follows up a case by regular visits to and does not have recurrence.
Case 3: Zhang, man, 60 years old, area just outside a city gate town, Hua County, Henan Province Da Tun people from village, existing 3 years of patient's scapulohumeral periarthritis, pain can not carry arm, can't be engaged in work, made anesthesia needle, did small needle knife, effect is undesirable, the invention ointment 5 that loses money in a business in August, 2010 pastes, pain disappears entirely, can be engaged in work, follows up a case by regular visits to and does not have recurrence.
Case 4: Liu, the man, 30 years old, area just outside a city gate town, Hua County, Henan Province Jia Gu people from village suffered from prolapse of lumbar intervertebral disc 3 years, sat of a specified duration and can't stand.Invalid at hospital admission, can't be engaged in work or physical labor.Lose money in a business in April, 2010 invention ointment 1 month, pain disappears entirely, can be engaged in work or physical labor, follows up a case by regular visits to and does not have recurrence.
Case 5: Jin, the woman, 34 years old, area just outside a city gate town, Hua County, Henan Province north pass people from village suffered from cervical spondylosis 5 years, and 24 hours fiber crops of both arms are cool, anxious often.The invention ointment 3 that loses money in a business in July, 2009 pastes, and the cool sense of both arms fiber crops is obviously gone down.After adhere to pasting 1 wheat harvesting period, symptom disappears entirely, follows up a case by regular visits to and does not have recurrence.
Specific embodiment:
In order to make those skilled in the art person understand the present invention program better, and above-mentioned purpose of the present invention, feature and advantage can be become apparent more, the present invention is further detailed explanation below in conjunction with embodiment.
Embodiment 1: choose raw material: Radix Aconiti Kusnezoffii 320 grams, Rhizoma Et Radix Notopterygii 330 grams, Rhizoma Arisaematis 230 grams, the Radix Angelicae Dahuricae 230 grams, Rhizoma Corydalis 160 grams, Radix Angelicae Sinensis 280 grams, Rhizoma Zingiberis 130 grams, Rhizoma Cyperi 260 grams, Borneolum Syntheticum 70 grams, Radix Angelicae Pubescentis 330 grams, Radix Notoginseng 230 grams, Radix Et Rhizoma Rhei 180 grams, Herba Ephedrae 180 grams.During making, make plaster with conventional method.
Embodiment 2: choose raw material: Radix Aconiti Kusnezoffii 320 grams, Rhizoma Et Radix Notopterygii 330 grams, Rhizoma Arisaematis 230 grams, the Radix Angelicae Dahuricae 230 grams, Rhizoma Corydalis 160 grams, Radix Angelicae Sinensis 280 grams, Rhizoma Zingiberis 130 grams, Rhizoma Cyperi 260 grams, Borneolum Syntheticum 70 grams, Radix Angelicae Pubescentis 330 grams, Radix Notoginseng 230 grams, Radix Et Rhizoma Rhei 180 grams, Herba Ephedrae 180 grams, Spica Prunellae 240 grams, Caulis Trachelospermi 140 grams, eupolyphaga 70 grams, Scorpio 80 grams.During making, make plaster with conventional method.
Embodiment 3: choose raw material: Radix Aconiti Kusnezoffii 320 grams, Rhizoma Et Radix Notopterygii 330 grams, Rhizoma Arisaematis 230 grams, the Radix Angelicae Dahuricae 230 grams, Rhizoma Corydalis 160 grams, Radix Angelicae Sinensis 280 grams, Rhizoma Zingiberis 130 grams, Rhizoma Cyperi 260 grams, Borneolum Syntheticum 70 grams, Radix Angelicae Pubescentis 330 grams, Radix Notoginseng 230 grams, Radix Et Rhizoma Rhei 180 grams, Herba Ephedrae 180 grams, Ramulus Cinnamomi 260 grams, Radix Saposhnikoviae 280 grams, Rhizoma Acori Graminei 280 grams, Colophonium 130 grams.During making, make plaster with conventional method.
Embodiment 4: choose raw material: Radix Aconiti Kusnezoffii 320 grams, Rhizoma Et Radix Notopterygii 330 grams, Rhizoma Arisaematis 230 grams, the Radix Angelicae Dahuricae 230 grams, Rhizoma Corydalis 160 grams, Radix Angelicae Sinensis 280 grams, Rhizoma Zingiberis 130 grams, Rhizoma Cyperi 260 grams, Borneolum Syntheticum 70 grams, Radix Angelicae Pubescentis 330 grams, Radix Notoginseng 230 grams, Radix Et Rhizoma Rhei 180 grams, Herba Ephedrae 180 grams, Spica Prunellae 240 grams, Caulis Trachelospermi 140 grams, eupolyphaga 70 grams, Scorpio 80 grams, Ramulus Cinnamomi 260 grams, Radix Saposhnikoviae 280 grams, Rhizoma Acori Graminei 280 grams, Colophonium 130 grams.During making, make plaster with conventional method.
The above; only be the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, anyly is familiar with those skilled in the art in the technical scope that the present invention discloses; the variation that can expect easily or replacement all should be encompassed within protection scope of the present invention.
Claims (4)
1. the plaster of treatment of arthritis and hyperosteogeny, it is characterized in that comprising following raw material by weight: 200～500 parts of Radix Aconiti Kusnezoffii, 200～500 parts of Rhizoma Et Radix Notopterygiis, 200～300 parts of Rhizoma Arisaematiss, 200～300 parts of the Radixs Angelicae Dahuricae, 100～300 parts of Rhizoma Corydalis, 200～400 parts of Radix Angelicae Sinensis, 100～200 parts of Rhizoma Zingiberiss, 200～400 parts of Rhizoma Cyperis, 50～100 parts of Borneolum Syntheticums, 200～500 parts of Radix Angelicae Pubescentiss, 200～300 parts of Radix Notoginseng, 100～300 parts of Radix Et Rhizoma Rhei, 100～300 parts in Herba Ephedrae, make plaster with conventional method.
2. according to the plaster of claims 1 described treatment of arthritis and hyperosteogeny, it is characterized in that also comprising following raw material by weight: 200～300 parts of Spica Prunellaes, 100～200 parts of Caulis Trachelospermis, 50～100 parts of eupolyphaga, 50～100 parts of Scorpio.
3. according to the plaster of claims 1 or 2 described treatment of arthritis and hyperosteogeny, it is characterized in that also comprising following raw material by weight: 200～400 parts of Ramulus Cinnamomi, 200～400 parts of Radix Saposhnikoviaes, 200～400 parts of Rhizoma Acori Graminei, 100～200 parts of Colophonium.
4. according to the plaster of claims 1 described treatment of arthritis and hyperosteogeny, it is characterized in that described drug component is: 350 parts of Radix Aconiti Kusnezoffii, 350 parts of Rhizoma Et Radix Notopterygiis, 250 parts of Rhizoma Arisaematiss, 250 parts of the Radixs Angelicae Dahuricae, 200 parts of Rhizoma Corydalis, 300 parts of Radix Angelicae Sinensis, 150 parts of Rhizoma Zingiberiss, 300 parts of Rhizoma Cyperis, 75 parts of Borneolum Syntheticums, 350 parts of Radix Angelicae Pubescentiss, 250 parts of Radix Notoginseng, 200 parts of Radix Et Rhizoma Rhei, 200 parts in Herba Ephedrae.
5Plaster according to claims 4 described treatment of arthritis and hyperosteogeny is characterized in that also comprising in the described drug component: 250 parts of Spica Prunellaes, 150 parts of Caulis Trachelospermis, 75 parts of eupolyphaga, 75 parts of Scorpio.
6Plaster according to claims 4 or 5 described treatment of arthritis and hyperosteogeny is characterized in that also comprising in the described drug component: 300 parts of Ramulus Cinnamomi, 300 parts of Radix Saposhnikoviaes, 300 parts of Rhizoma Acori Graminei, 150 parts of Colophonium.
7, according to the plaster of claims 3 described treatment of arthritis and hyperosteogeny, it is characterized in that: describedly make plaster with conventional method, refer to the A group: Radix Aconiti Kusnezoffii Preparata, Rhizoma Arisaematis, Rhizoma Corydalis, Radix Angelicae Pubescentis, Radix Angelicae Sinensis, Radix Notoginseng, Spica Prunellae, Caulis Trachelospermi, eupolyphaga, Scorpio, broken back is standby; The B group: Rhizoma Et Radix Notopterygii, the Radix Angelicae Dahuricae, Rhizoma Zingiberis, Rhizoma Cyperi (processed), Radix Et Rhizoma Rhei, Herba Ephedrae, Ramulus Cinnamomi, Radix Saposhnikoviae, Rhizoma Acori Graminei, Colophonium, standby after pulverizing; The C group: it is standby that Borneolum Syntheticum is pulverized the back; Get Oleum sesami and go into and change slow fire after a pot intense fire boils, A is organized raw material put into, stir, about 30-40 minute fried extremely withered and yellow, pulls out; Be lowered to B group slow fire again, stirred about 20 minutes, from fire, cool after-filtration after filtering with fine sand cloth, is gone up intense fire again, fire to dripping into pearl, is removed in following Plumbum preparatium, and the stirring of cool slightly Borneolum Syntheticum down is even.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105131063A CN101979081A (en) | 2010-10-20 | 2010-10-20 | Plaster for treating arthritis and hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105131063A CN101979081A (en) | 2010-10-20 | 2010-10-20 | Plaster for treating arthritis and hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101979081A true CN101979081A (en) | 2011-02-23 |
Family
ID=43599637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105131063A Pending CN101979081A (en) | 2010-10-20 | 2010-10-20 | Plaster for treating arthritis and hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101979081A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988535A (en) * | 2012-10-13 | 2013-03-27 | 慈溪市锐玛电子有限公司 | Medicine for treating arthrophlogosis |
| CN103007244A (en) * | 2013-01-05 | 2013-04-03 | 刘兆艳 | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases |
| CN107441265A (en) * | 2017-08-23 | 2017-12-08 | 陕西医大血友病研究院 | A kind of anti-inflammatory, repercussive and analgesic cream for being used to treat hemophiliac joints inflammation and hemotoncus |
-
2010
- 2010-10-20 CN CN2010105131063A patent/CN101979081A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988535A (en) * | 2012-10-13 | 2013-03-27 | 慈溪市锐玛电子有限公司 | Medicine for treating arthrophlogosis |
| CN103007244A (en) * | 2013-01-05 | 2013-04-03 | 刘兆艳 | Traditional Chinese medicine composition for treating cervical vertebra and lumbar vertebra diseases |
| CN107441265A (en) * | 2017-08-23 | 2017-12-08 | 陕西医大血友病研究院 | A kind of anti-inflammatory, repercussive and analgesic cream for being used to treat hemophiliac joints inflammation and hemotoncus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN108553633A (en) | A kind of Dressed plaster and preparation method thereof for treating rheumatism and neck-shoulder pain, lumbago and leg pain | |
| CN103585590A (en) | Rheumatism ostalgia plaster | |
| CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
| CN107050118B (en) | Traditional Chinese medicine plaster for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN102895601A (en) | Medicament for treating neck-shoulder pain | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN102895447A (en) | Chinese medicinal ointment for treating orthopaedic diseases and preparation method thereof | |
| CN101979081A (en) | Plaster for treating arthritis and hyperosteogeny | |
| CN1621051A (en) | Hyperosteogeny plaster | |
| CN108310070B (en) | A Chinese medicinal composition for treating pain caused by hyperosteogeny of lumbar vertebra and cervical vertebra, and its preparation method | |
| CN104096087A (en) | Externally applied plaster for treating lumbar disc herniation | |
| CN103860676B (en) | A kind of Chinese medicine for external application for the treatment of lumbar muscle strain and preparation method thereof | |
| CN101700395B (en) | Ointment for curing hyperosteogeny | |
| CN102416049B (en) | Small square type rheumatoid swelling diminishing and pain eliminating plaster and preparation method thereof | |
| CN100493544C (en) | A kind of external medicine for treating rheumatism | |
| CN105412206A (en) | Traditional Chinese medicine preparation with relaxing tendon and dissipating hard mass effects | |
| CN104971286A (en) | Traditional Chinese medicine composition for treating shoulder, waist and leg discomfort | |
| CN104706749A (en) | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion | |
| CN102441148A (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN103989968A (en) | Oral traditional Chinese medicinal composition for treating cervical spinal stenosis | |
| CN102885943A (en) | External Chinese medicinal liniment for treating psoriasis | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20110223 |